OX40/OX40L Inhibitors in Atopic Dermatitis: Current Evidence on Short-term Safety.

IF 3.8 4区医学 Q1 DERMATOLOGY

Acta dermato-venereologica Pub Date : 2026-10-12 DOI:10.2340/actadv.v106.adv-2026-0665

Kian Karimian, Daniel Isufi, Mikkel Bak Jensen, Raj Chovatiya, Christopher G Bunick, Tiago Torres, Jakob Ferløv Baselius Schwensen, Nikolai Loft

引用次数: 0

查看原文本刊更多论文

OX40/OX40L抑制剂治疗特应性皮炎：近期安全性证据

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta dermato-venereologica 医学-皮肤病学

CiteScore

4.90

自引率

2.80%

发文量

210

审稿时长

6-12 weeks

期刊介绍： Acta Dermato-Venereologica publishes high-quality manuscripts in English in the field of Dermatology and Venereology, dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume also features a number of Review articles in special areas, as well as short Letters to the Editor to stimulate debate and to disseminate important clinical observations. Acta Dermato-Venereologica has rapid publication times and is amply illustrated with a large number of colour photographs.